These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9009661)

  • 61. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases.
    Mylonakis E; Barlam TF; Flanigan T; Rich JD
    Chest; 1998 Jul; 114(1):251-62. PubMed ID: 9674477
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Invasive aspergillosis: clinical manifestations and treatment].
    Lumbreras C; Gavaldá J
    Rev Iberoam Micol; 2003 Sep; 20(3):79-89. PubMed ID: 15456363
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Aspergillus fumigatus sinusitis in AIDS].
    Geissmann F; Hennequin C; Maarek H; Viard JP
    Presse Med; 1993 Nov; 22(35):1792. PubMed ID: 8115323
    [No Abstract]   [Full Text] [Related]  

  • 65. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient.
    Finer G; Greenberg D; Leibovitz E; Leiberman A; Shelef I; Kapelushnik J
    Scand J Infect Dis; 2002; 34(3):227-9. PubMed ID: 12030404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current management of fungal infections.
    Meis JF; Verweij PE
    Drugs; 2001; 61 Suppl 1():13-25. PubMed ID: 11219547
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Invasive aspergillosis of the paranasal sinuses and orbit: can you save the eye?
    Adler SC; Isaacson G; Sasaki CT
    Am J Otolaryngol; 1997; 18(4):230-4. PubMed ID: 9242872
    [No Abstract]   [Full Text] [Related]  

  • 68. Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation.
    Paniagua Martin MJ; Marzoa Rivas R; Barge Caballero E; Grille Cancela Z; Fernandez CJ; Solla M; Pedrosa V; Rodriguez Fernandez JA; Herrera JM; Castro-Beiras A; Crespo-Leiro MG
    Transplant Proc; 2010 Oct; 42(8):3014-6. PubMed ID: 20970596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exogenous Aspergillus niger endophthalmitis in a patient with a filtering bleb.
    Krzystolik MG; Ciulla TA; Topping TM; Baker AS
    Retina; 1997; 17(5):461-2. PubMed ID: 9355201
    [No Abstract]   [Full Text] [Related]  

  • 70. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.
    Koss T; Bagheri B; Zeana C; Romagnoli MF; Grossman ME
    J Am Acad Dermatol; 2002 Jun; 46(6):945-7. PubMed ID: 12063497
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Invasive pulmonary aspergillosis].
    Părău A
    Pneumologia; 2001; 50(3):171-6. PubMed ID: 11977489
    [No Abstract]   [Full Text] [Related]  

  • 72. Prophylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melbourne Hospital experience.
    Grigg A
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():75-80. PubMed ID: 11801586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
    Sato A; Nakatani K; Matsushita Y; Matsuo H; Yamadori H; Kurasawa T; Ikeda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1141-5. PubMed ID: 8544389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
    Monforte V; Ussetti P; López R; Gavaldà J; Bravo C; de Pablo A; Pou L; Pahissa A; Morell F; Román A
    J Heart Lung Transplant; 2009 Feb; 28(2):170-5. PubMed ID: 19201343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Histoplasmosis: not only a tropical disease].
    Bregani ER; Van Tien T; Ceraldi T; Delfitto C; Figini G
    Recenti Prog Med; 2000; 91(7-8):396-401. PubMed ID: 10932927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pulmonary aspergilloma in a patient with AIDS.
    Höhler T; Schnütgen M; Mayet WJ; Meyer zum Büschenfelde KH
    Thorax; 1995 Mar; 50(3):312-3; discussion 317-8. PubMed ID: 7660348
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early diagnosis of invasive aspergillosis.
    Malnick SD; Shtalrid M; Landau Z
    Lancet; 2000 Jun; 355(9220):2076-7. PubMed ID: 10885382
    [No Abstract]   [Full Text] [Related]  

  • 80. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
    Chryssanthou E
    Scand J Infect Dis; 1997; 29(5):509-12. PubMed ID: 9435042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.